BiomeBank has appointed a former chief executive to become the new chair of its clinical stage biotech company. Australian investors have been given the green light by the companys new chairman, Dr Chris Hall, who has previously served as the chair.
Source: us.acrofan.comPublished on 2022-01-19
Related news
- ReGrained SuperGrain+ earns first upcycled food certification to catalyze demand for growing industry
- The Greenwashing of European Banks
- Accelerating Investment in Natural Climate Solutions
- Gains from new reporting rules
- Wild west : ESG disclosures leaving investors baffled
- Long - standing systems for sustainable farming could feed people and the planet if industry is willing to step back
- ESG & EPC : A Match Made for Real Estate Finance Heaven ? | White & Case LLP
- These Sweet Shades Protect Your Peepers and the Planet
- Wild west : Disclosure guidance for ESG investing leaves investors baffled
- EU Lawmakers Push for Stricter Green Bond Rules Without Nuclear